ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Neurology

Top Neurology Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DALE PCSOLYAR M.D.

Neurology

1,383

$245K

147
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$177
Average prescription price

Avg: $241

JONATHAN BEKENSTEIN M.D.

Neurology

1,372

$731K

153
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$533
Average prescription price

Avg: $241

LARRY STEPHENSON MD

Neurology

1,367

$181K

98
71 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 26%

$133
Average prescription price

Avg: $241

KRISTIN WILLIAMS MD

Neurology

1,359

$257K

151
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 26%

$189
Average prescription price

Avg: $241

XIANGHUI CAO MD

Neurology

1,358

$142K

179
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 26%

$105
Average prescription price

Avg: $241

WILLIAM WALLACE

Neurology

1,313

$332K

269
194 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 26%

$253
Average prescription price

Avg: $241

KAREN THOMAS DO

Neurology

1,303

$275K

183
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$211
Average prescription price

Avg: $241

AYSEGUL SOYER M.D.

Neurology

1,295

$253K

119
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$196
Average prescription price

Avg: $241

ALAN SCHULMAN M.D.

Neurology

1,289

$223K

240
181 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 26%

$173
Average prescription price

Avg: $241

NOMA REHMAN MD, MBBS

Neurology

1,283

$254K

258
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 26%

$198
Average prescription price

Avg: $241

DAWEN BU MD

Neurology

1,279

$210K

214
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 26%

$164
Average prescription price

Avg: $241

CARMEN FUENTES MD

Neurology

1,272

$135K

176
122 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 26%

$106
Average prescription price

Avg: $241

PARI NIKPEY MD

Neurology

1,258

$214K

141
101 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 26%

$170
Average prescription price

Avg: $241

FIRAS BEITINJANEH M.D.

Neurology

1,251

$104K

131
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 26%

$83
Average prescription price

Avg: $241

PAUL COLOPY MD

Neurology

1,232

$157K

156
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 26%

$128
Average prescription price

Avg: $241

MARCO CASTRO M.D.

Neurology

1,220

$309K

107
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 26%

$254
Average prescription price

Avg: $241

JOSEPH FERRARA MD

Neurology

1,209

$360K

274
181 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 26%

$298
Average prescription price

Avg: $241

BIBHUTI MISHRA MD

Neurology

1,208

$407K

140
84 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 26%

$337
Average prescription price

Avg: $241

PHILIP ODONNELL M.D.

Neurology

1,206

$240K

137
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 26%

$199
Average prescription price

Avg: $241

ELIZABETH WATERHOUSE M.D.

Neurology

1,198

$377K

101
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 26%

$315
Average prescription price

Avg: $241

DANIEL CHEHEBAR D.O.

Neurology

1,192

$127K

131
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$107
Average prescription price

Avg: $241

LINDA SIGMUND M.D.

Neurology

1,190

$371K

132
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 26%

$312
Average prescription price

Avg: $241

ROBERT ADAMS MD

Neurology

1,168

$221K

148
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 26%

$189
Average prescription price

Avg: $241

HODA HACHICHO M.D.

Neurology

1,159

$209K

109
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 26%

$180
Average prescription price

Avg: $241

ANNA HRISTOVA M.D.

Neurology

1,156

$496K

89
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 26%

$429
Average prescription price

Avg: $241

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank